在HCC中ITH的非侵入性预后分类,具有多omics见解和治疗影响
Yangyang Xie1,2,3,4, Fang Wang5,6,7,8, Jingwei Wei9,10
1Zhejiang Key Laboratory of Multi-omics Precision Diagnosis and Treatment of Liver Diseases, Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, 310016 Hangzhou, China.
Science advances
|May 2, 2025
概括
这项研究介绍了放射性ITH (RITH) 现象型,一种非侵入性方法来分类肝细胞癌 (HCC) 异质性. 瑞思表型与预后相关,并揭示了分子驱动因素,有助于个性化HCC治疗.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 基因组学就是基因组学.
背景情况:
- 内异质性 (ITH) 显著影响肝细胞癌 (HCC) 的治疗结果和复发.
- 目前缺乏用于全面评估HCC中ITH的非侵入性方法.
- 了解ITH的分子基础对于开发向疗法至关重要.
研究的目的:
- 开发和验证使用放射学在HCC中ITH的非侵入性预后分类.
- 阐明通过放射学识别的ITH表型背后的分子机制.
- 基于ITH分子特征,探索HCC的潜在治疗点.
主要方法:
- 使用来自五个中心851名HCC患者的多序MRI数据开发放射性ITH (RITH) 现型.
- 对RITH表型与患者预后和病理ITH的相关性分析.
- 综合的多学科分析,以确定与RITH表型相关的分子途径.
主要成果:
- 里斯表型与患者预后和病理性ITH都有很强的相关性.
- 多omics分析显示,高RITH瘤的特征是与癌症相关的纤维细胞和细胞外矩阵重塑.
- 细胞外矩阵-受体相互作用途径被确定为高RITHHHCC的潜在治疗标.
结论:
- 基于放射学的RITH表型提供了一种非侵入性的方法来对ITH在HCC中进行分类.
- 该研究通过将放射学特征与分子机制联系起来,提高了ITH的生物解释性.
- 这种方法为HCC的个性化治疗策略提供了一个框架,并可能适用于其他固体瘤.
相关概念视频
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


